Singapore markets closed

Regeneron Pharmaceuticals, Inc. (REGN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
618.11+6.89 (+1.13%)
At close: 04:00PM EST
620.95 +2.84 (+0.46%)
After hours: 06:11PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
Total revenue
13,542,900
8,497,100
7,863,400
6,710,800
Cost of revenue
1,808,000
1,119,900
782,200
434,100
Gross profit
11,734,900
7,377,200
7,081,200
6,276,700
Operating expenses
Research development
2,867,000
2,735,000
3,036,600
2,186,100
Selling general and administrative
1,568,800
1,346,000
1,834,800
1,556,200
Total operating expenses
4,260,800
3,800,600
4,871,400
3,742,300
Operating income or loss
7,474,100
3,576,600
2,209,800
2,534,400
Interest expense
58,000
56,900
30,200
28,200
Total other income/expenses net
630,900
290,700
249,500
47,300
Income before tax
8,047,000
3,810,400
2,429,100
2,553,500
Income tax expense
1,051,500
297,200
313,300
109,100
Income from continuing operations
6,995,500
3,513,200
2,115,800
2,444,400
Net income
6,995,500
3,513,200
2,115,800
2,444,400
Net income available to common shareholders
6,995,500
3,513,200
2,115,800
2,444,400
Basic EPS
-
32.65
19.38
22.65
Diluted EPS
-
30.52
18.46
21.29
Basic average shares
-
107,600
109,200
107,900
Diluted average shares
-
115,100
114,600
114,800
EBITDA
-
4,103,200
2,669,600
2,729,900